NCT02562274

Brief Summary

This study the investigators aimed to determine the effect of the herbal porridge containing the combined extract of mulberry and Vietnamese coriander (MP) on cognitive function and bone formation markers of menopausal women. Forty-five participants were randomly assigned to receive a placebo or MP (50, 1500 mg) treatments once daily for 8 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P50-P75 for phase_1 healthy

Timeline
Completed

Started Sep 2014

Longer than P75 for phase_1 healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 18, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 29, 2015

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

March 1, 2016

Status Verified

February 1, 2016

Enrollment Period

1.2 years

First QC Date

September 18, 2015

Last Update Submit

February 27, 2016

Conditions

Keywords

MenopauseCognitive impairmentWorking memoryBone formation markersOsteoporosis

Outcome Measures

Primary Outcomes (1)

  • Attention (N100) and cognitive processing (P300) determine by using Event Related Potential (Auditory oddball paradigm).

    3 months

Secondary Outcomes (5)

  • Accuracy and time response of working memory by using computerized batteries test (CDR)

    3 months

  • Bone formation marker by using serum calcium, serum alkaline phosphatase and serum osteocalcin

    2 months

  • Acetylcholinesterase and monoamine oxidase type A ,B activities in serum

    2 months

  • Psychological symptom by using SCL-90 questionnaire

    3 months

  • Consumption safety of MP product by using the electrocardiogram (ECG), hematology, blood chemistry and blood pressure measurement.

    3 months

Study Arms (3)

Placebo group

PLACEBO COMPARATOR

Subjects are received the placebo product which has same color and smell look like the herbal porridge containing the combined extract of mulberry and Vietnamese coriander (MP) treatments once daily for 8 weeks

Dietary Supplement: Placebo

MP 50 mg/day

ACTIVE COMPARATOR

Subjects are received the herbal porridge containing the combined extract of mulberry and Vietnamese coriander (MP) 50 mg/day treatments once daily for 8 weeks

Dietary Supplement: MP 50 mg/day

MP 1500 mg/day

ACTIVE COMPARATOR

Subjects are received the herbal porridge containing the combined extract of mulberry and Vietnamese coriander (MP) 1500 mg/day treatments once daily for 8 weeks

Dietary Supplement: MP 1500 mg/day

Interventions

PlaceboDIETARY_SUPPLEMENT

Subjects are received placebo treatments once daily for 8 weeks

Placebo group
MP 50 mg/dayDIETARY_SUPPLEMENT

Subjects are received MP 50 mg/day treatments once daily for 8 weeks

MP 50 mg/day
MP 1500 mg/dayDIETARY_SUPPLEMENT

Subjects are received MP 1500 mg/day treatments once daily for 8 weeks

MP 1500 mg/day

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy perimenopausal and postmenopausal women (\<5 years menstruation cessation) who live in Northeastern of Thailand.
  • Aged between 45-60 years old
  • All volunteers don't have serious physical illness such as diabetes, high blood pressure, heart disease, liver disease, kidney disease, lung disease, allergies and mental disorder.
  • All volunteers don't get medicine or hormone or other medicines that affect the nervous system and bone during the trial and within three months before the start of the test.
  • All volunteers don't smoking more than 10 pieces/ day
  • All volunteers don't have alcohol addiction
  • On the day of the study, all volunteers felt well and refrain from drinking tea, coffee or alcohol at least 12 hour.

You may not qualify if:

  • Volunteers who have been diagnosed with one of the following; cardiovascular diseases, respiratory diseases, neuropsychological diseases, head injury, diabetes mellitus, liver disease, cancer, autoimmune disease, hematological disorder, and gout or high uric acid.
  • Volunteers who exposed to pesticides during one week before the test.
  • Volunteers who have been Hysterectomy and/or Oophorectomy
  • Volunteers who use hormone or any drug that effect on Hypothalamic Pituitary Gonadal axis and nervous system.
  • Volunteers who require supplements or any drug that effect on the nervous system by order of the doctor during trial.
  • Alcohol addiction
  • Smoking addiction (smoking more than 10 pieces/ day)
  • Athlete or volunteers who have a regular exercise more than 3 time/weeks
  • Volunteers who don't follow instructions during the trial.
  • Volunteers who participate in other projects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jitanaporn Wattanathorn

Khon Kaen, Changwat Khon Kaen, 40002, Thailand

Location

MeSH Terms

Conditions

Cognitive DysfunctionOsteoporosis

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Jintanaporn Wattanathorn, Ph.D.

    Khon Kaen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Doctor

Study Record Dates

First Submitted

September 18, 2015

First Posted

September 29, 2015

Study Start

September 1, 2014

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

March 1, 2016

Record last verified: 2016-02

Locations